He, B., Dai, L., Zhang, X., Chen, D., Wu, J., Feng, X., . . . Zheng, S. (2018). The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction. Int J Biol Sci.
Dyfyniad Arddull ChicagoHe, Bin, et al. "The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma Alone and Synergistically in Combination With Sorafenib By G0/G1 Phase Arrest and Apoptosis Induction." Int J Biol Sci 2018.
Dyfyniad MLAHe, Bin, et al. "The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma Alone and Synergistically in Combination With Sorafenib By G0/G1 Phase Arrest and Apoptosis Induction." Int J Biol Sci 2018.